D-0530-2023 Class II Ongoing
FDA drug recall D-0530-2023 was initiated by Hetero USA Inc on Mar 14, 2023 and is designated Class II. Reason for recall: CGMP Deviations: Discoloration The recall status is ongoing. Affected quantity: 2,352 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 19, 2023
- Initiation Date
- Mar 14, 2023
- Product Quantity
- 2,352 bottles
Product description
Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10
Reason for recall
CGMP Deviations: Discoloration
Distribution pattern
Nationwide within the United States
Code information
Lot #: PAN22542, Exp. Date: 9/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0530-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026